#astrazeneca

[ follow ]
#pharmaceuticals #investment #flu-vaccine #vaccination-rates #public-health #us-investment #manufacturing
#flu-vaccine
more#flu-vaccine
Miscellaneous
fromScary Mommy
3 weeks ago

You Can Now Give Your Family The Nasal Flu Vaccine At Home

Flu vaccination rates are declining due to various barriers, and AstraZeneca's FluMist offers a convenient at-home alternative.
US politics
fromBusiness Matters
1 month ago

AstraZeneca to invest $50bn in US amid pressure from Trump administration

AstraZeneca plans to invest $50 billion in the U.S. by 2030, pressured by the Trump administration.
fromFast Company
1 month ago

AstraZeneca announces $50 billion investment in U.S. as Trump's tariffs loom

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, responding to President Trump's tariff policy.
US politics
#investment
fromFortune
1 month ago
Healthcare

AstraZeneca CEO Pascal Soriot on why he's building in the U.S.: 'Europe is losing ground'

fromFortune
1 month ago
Healthcare

AstraZeneca CEO Pascal Soriot on why he's building in the U.S.: 'Europe is losing ground'

more#investment
fromwww.theguardian.com
1 month ago

AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats

AstraZeneca's $50bn investment aims to establish a new drug manufacturing facility in Virginia and expand research and development across various US states, highlighting a significant commitment to US operations in response to looming tariffs on foreign pharmaceuticals.
US politics
fromLondon Business News | Londonlovesbusiness.com
2 months ago

Reeves hit with another blow as AstraZeneca considering leaving the UK

Sir Pascal Soriot has repeatedly highlighted the need for Europe to enhance its incentives for new medicines, warning that jobs could relocate to the US if these conditions remain unchanged.
UK news
Canada news
fromwww.theguardian.com
2 months ago

If AstraZeneca goes to the US it will be a major blow for London and Labour

Pascal Soriot is considering moving AstraZeneca's corporate base to the US, impacting the company's UK presence and raising concerns in the scientific community.
[ Load more ]